| Literature DB >> 12176778 |
A T C Chan1, P M L Teo, P J Johnson.
Abstract
Nasopharyngeal carcinoma (NPC) is endemic in southern China where genetic abnormalities and Epstein-Barr virus (EBV) infection are critical in the pathogenesis of the disease. Circulating EBV-DNA has been shown to improve prognostication and monitoring of NPC patients. Radiotherapy is the mainstay treatment for early disease and concurrent cisplatin/radiotherapy has been demonstrated to prolong survival in locoregionally advanced disease. Ongoing studies of targeting agents and immunotherapeutic approaches may further improve treatment results.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12176778 DOI: 10.1093/annonc/mdf179
Source DB: PubMed Journal: Ann Oncol ISSN: 0923-7534 Impact factor: 32.976